Published on FiercePharma (http://www.fiercepharma.com)

Biogen reports 11th PML case for Tysabri

By tracy

Created Jul 27 2009 - 10:10am

An eleventh patient taking Biogen Idec and Elan's multiple sclerosis drug Tysabri has developed a potentially deadly brain infection, the company announced in its weekly update on PML cases. Report [1]

Biogen Idec
Tysabri

Source URL: http://www.fiercepharma.com/story/biogen-reports-11-pml-case-tysabri/2009-07-27

Links:
[1] http://www.reuters.com/article/rbssHealthcareNews/idUSN2448723320090724